Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.-论文-万方医学网

作者： Hongmin,Li ^[1] ; Jiang,Ji ^[1] ; Yali,Du ^[1] ; Yuzhou,Huang ^[1] ; Hao,Gu ^[2] ; Miao,Chen ^[1] ; RunHui,Wu ^[2] ; Bing,Han ^[3]

作者单位： Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[1] Hematology-Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. ^[2] Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: hanbing_li@sina.com.cn. ^[3]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);贫血, 溶血性, 自身免疫性(Anemia, Hemolytic, Autoimmune);自身免疫(Autoimmunity);儿童(Child);儿童, 学龄前(Child, Preschool);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);免疫抑制剂(Immunosuppressive Agents);婴儿(Infant);婴儿, 新生(Infant, Newborn);男(雄)性(Male);中年人(Middle Aged);黏膜炎(Mucositis);紫癜, 血小板减少性, 特发性(Purpura, Thrombocytopenic, Idiopathic);复发(Recurrence);回顾性研究(Retrospective Studies);西罗莫司(Sirolimus);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);血小板减少(Thrombocytopenia);治疗结果(Treatment Outcome)

DOI 10.1016/j.exphem.2020.08.001

PMID 32771553

发布时间 2020-12-14

检索历史清除

Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.

Experimental hematology

相似文献

Experimental hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.

Experimental hematology

相似文献

Experimental hematology

相关期刊

检索历史清除